To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS).
Clinical trial NCT07479043 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07479043
- Sponsor
- Breathe Biologics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.